A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

NCT05151744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Vamikibart
DRUG: Ranibizumab
OTHER: Sham Procedure

Sponsor

Hoffmann-La Roche